GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for uncharacterized oxidoreductase ML1669 (O69462)

Analyse AlphaFold monomer V2.0 prediction for uncharacterized oxidoreductase ML1669… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
O69462
Type
protein
Length
282 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xBeB220F0B5b0C48F46B5DDd3E3b071BC0827f8D6
Molecule
Uncharacterized oxidoreductase ML1669
UniProt
O69462
Pockets
2 · best druggability 0.62

Structure

1 distinct chain · 43% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AUncharacterized oxidoreductase ML1669protein28243% helix, 17% strandO69462

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12080.620.8336empty
2790.350.7615empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.